EAM Investors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-250,789
| Closed | -$256K | – | 349 |
|
|
2024
Q4 | $256K | Buy |
+250,789
| New | +$256K | 0.04% | 251 |
|
|
2018
Q2 | – | Sell |
-219,415
| Closed | -$4.17M | – | 349 |
|
|
2018
Q1 | $4.17M | Buy |
219,415
+141,416
| +181% | +$2.69M | 0.69% | 20 |
|
|
2017
Q4 | $1.28M | Sell |
77,999
-135,028
| -63% | -$2.21M | 0.23% | 175 |
|
|
2017
Q3 | $3.2M | Buy |
213,027
+101,541
| +91% | +$1.52M | 0.42% | 60 |
|
|
2017
Q2 | $981K | Buy |
+111,486
| New | +$981K | 0.16% | 199 |
|
|
2016
Q1 | – | Sell |
-94,183
| Closed | -$860K | – | 338 |
|
|
2015
Q4 | $860K | Buy |
+94,183
| New | +$860K | 0.11% | 291 |
|
|
2014
Q3 | – | Sell |
-61,248
| Closed | -$935K | – | 355 |
|
|
2014
Q2 | $935K | Sell |
61,248
-17,690
| -22% | -$270K | 0.18% | 297 |
|
|
2014
Q1 | $1.43M | Sell |
78,938
-20,955
| -21% | -$379K | 0.26% | 175 |
|
|
2013
Q4 | $1.39M | Buy |
+99,893
| New | +$1.39M | 0.25% | 180 |
|